UnitedHealth Group Incorporated (NYSE:UNH) is High Note Wealth LLC’s 7th Largest Position

High Note Wealth LLC raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 20,996 shares of the healthcare conglomerate’s stock after acquiring an additional 621 shares during the quarter. UnitedHealth Group makes up 4.2% of High Note Wealth LLC’s investment portfolio, making the stock its 7th largest position. High Note Wealth LLC’s holdings in UnitedHealth Group were worth $11,054,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the business. Keebeck Wealth Management LLC grew its stake in UnitedHealth Group by 11.6% in the 2nd quarter. Keebeck Wealth Management LLC now owns 10,788 shares of the healthcare conglomerate’s stock worth $5,185,000 after acquiring an additional 1,122 shares during the period. Ascension Capital Advisors Inc. acquired a new position in shares of UnitedHealth Group during the 3rd quarter valued at about $216,000. Physician Wealth Advisors Inc. purchased a new stake in UnitedHealth Group in the third quarter valued at approximately $207,000. Bartlett & Co. LLC raised its stake in UnitedHealth Group by 5.7% during the third quarter. Bartlett & Co. LLC now owns 164,353 shares of the healthcare conglomerate’s stock worth $82,865,000 after purchasing an additional 8,873 shares during the period. Finally, Great Valley Advisor Group Inc. increased its holdings in shares of UnitedHealth Group by 5.8% during the 3rd quarter. Great Valley Advisor Group Inc. now owns 34,297 shares of the healthcare conglomerate’s stock worth $17,292,000 after buying an additional 1,884 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares in the company, valued at approximately $16,977,233.31. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. Company insiders own 0.35% of the company’s stock.

UnitedHealth Group Trading Up 0.2 %

Shares of NYSE UNH opened at $493.14 on Thursday. UnitedHealth Group Incorporated has a 12-month low of $445.68 and a 12-month high of $554.70. The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 0.62. The stock’s 50 day simple moving average is $503.73 and its 200 day simple moving average is $518.79. The company has a market cap of $454.64 billion, a price-to-earnings ratio of 20.69, a price-to-earnings-growth ratio of 1.34 and a beta of 0.54.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share for the quarter, topping analysts’ consensus estimates of $5.98 by $0.18. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The business had revenue of $94.43 billion for the quarter, compared to analysts’ expectations of $92.13 billion. During the same quarter last year, the company earned $5.34 EPS. The company’s revenue for the quarter was up 14.1% compared to the same quarter last year. Equities research analysts expect that UnitedHealth Group Incorporated will post 27.82 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were given a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a yield of 1.52%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 31.54%.

Wall Street Analysts Forecast Growth

Several brokerages have commented on UNH. Piper Sandler dropped their price target on UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating for the company in a research note on Wednesday, January 17th. Barclays started coverage on shares of UnitedHealth Group in a research report on Wednesday, March 6th. They set an “overweight” rating and a $551.00 price target on the stock. Royal Bank of Canada reissued an “outperform” rating and issued a $596.00 target price on shares of UnitedHealth Group in a research note on Thursday, February 29th. Bank of America reaffirmed a “buy” rating and issued a $675.00 target price on shares of UnitedHealth Group in a research report on Thursday, March 7th. Finally, HSBC reaffirmed a “reduce” rating and issued a $480.00 price objective (down previously from $550.00) on shares of UnitedHealth Group in a research report on Monday, December 18th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, fifteen have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $579.33.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.